From: The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis
Variables | PCOS (n = 102) | Control (n = 102) | p-value |
---|---|---|---|
Age (years) | 30.88 ± 8.36 | 30.68 ± 4,36 | 0.07 |
BMI (kg/m2) | 29.02 ± 5.64 | 26.55 ± 6.07 | p ≤ 0.001 |
WHR | 0.78 ± 0.22 | 0,71 ± 0.14 | 0.006 |
Ferriman Gallwey Score (FGS) | 12.43 ± 5.80 | 5.88 ± 2.06 | p ≤ 0.001 |
HOMA-IR | 2.92 ± 1.89 | 1.78 ± 0.97 | p ≤ 0.001 |
CRP | 11.67 ± 2.73 | 6.53 ± 3.85 | p ≤ 0.001 |
LH/FSH ratio | 1.30 ± 1.03 | 0.78 ± 0.56 | p ≤ 0.001 |
Total Testosterone (ng/dl) | 0.74 ± 0.36 | 0.51 ± 0.20 | p ≤ 0.001 |
Triglycerides (mg/dl) | 117.85 ± 48.89 | 91.80 ± 38.09 | p ≤ 0.001 |
Total Cholesterol (mg/dl) | 192.21 ± 43.59 | 169.45 ± 30.12 | p ≤ 0.001 |
LDL (mg/dl) | 116.95 ± 41.63 | 99.50 ± 26.46 | p ≤ 0.001 |
HDL (mg/dl) | 51.70 ± 10.45 | 52.74 ± 11.54 | 0.848 |